Born and raised in Kenya, Dr. Obama studied in Germany, obtaining a Masters degree at the University of Heidelberg. She completed her doctorate studies at the University of Bayreuth and also graduated from the Berlin Film and Television Academy. Dr. Obama lived and worked in Germany and the UK for several years before returning to Kenya to work for the humanitarian agency, CARE International. A key component of her work there was to create and coordinate Sport for Social Change Network, a global initiative that uses sport as a tool for social change. Dr. Obama is the Director of the Sauti Kuu Foundation (www.sautikuufoundation.org), which she founded in 2010 Dr Auma Obama. Sauti Kuu (Kiswahili for ‘Powerful Voices’) seeks to give a voice to financially and socially disadvantaged children and youth. Using a Self-Help Model of intervention the Foundation works to unlock their potential and enable them to improve their lives. Dr Obama also has held/ holds the following positions: Trustee of the Jacobs Foundation (2011 – 2015), Councilor of the World Future Council (2015 - Current), Patron of the Storymoja International Festival (2014 – Current) and the WELT Business Club (2017). Trustee of the Stiftung Lesen (German Reading Foundation (2015 – 2017), and a Council Member of the Kilimanjaro Initiative since 2014. Trustee of the Jim Button Foundation, Dr. Obama is the Initiator of the Sauti Kuu Act Now Youth Awards. Dr Obama is also a published author. Her memoir ‘Das Leben kommt immer dazwischen’, was first written and published in German in 2010. The English edition ‘And Then Life Happens’ later came out in 2012. She has been awarded numerous prizes for her humanitarian work as well as an international Speaker. Dr. Obama, is an alumni of the Rockefeller Foundation‘s Bellagio Centre Residency Program.
Dr Arun Shanbhag, PhD, MBA is the Chief Innovation Officer, Manipal Academy of Higher Education and Professor of Biomedical Engineering at the Manipal Institute of Technology. Previously, he was on the faculty of Orthopedic Surgery, Harvard Medical School, Boston. Dr Shanbhag is the recent recipient of the Bill & Melinda Gates Foundation Grand Challenge Explorations Award. At the Innovation Center, Dr. Shanbhag inspires students to follow design thinking principles and develop innovations to solve local problems. The Innovation Center organizes a variety of competitions and challenges where students develop interdisciplinary teams, come up with socially relevant innovation, develop working
Ashish Sharma, PhD is a Clinical/Medical leader with management experience and a passion for healthcare. Currently working at Roche Diagnostics as Clinical Science Leader with a major focus on leading companion diagnostics projects for Oncology along with translation of Medical Strategy to Clinical Development. Ashish has over a decade of diverse experience in preclinical & clinical development of novel diagnostic biomarkers and therapies. He has previously worked as Scientist/Team Leader at various matrix-structured organizations such as UniversitätsSpital Zürich and Cellworks Group Inc. where he handled cross functional global projects in Clinical and Pharmaceutical domains. Ashish, received his Ph.D. from University Hospital of Zürich, Switzerland in Radiation Oncology and has nearly twenty publications and over 500 citations.
Babette Simon is Associate Professor at the Medical Faculty Paris Descartes and former Managing Director and Regional Vice President of Medtronic Germany. Prior she has held the position of the Chief Medical Officer and Chairwomen of the University Medical Center Mainz and as the President of the Carl von Ossietzky University Oldenburg, establishing a novel European Medical School in cooperation with the Dutch University Groningen She has wide national and international experience across the health system in non-private and private organizations with a strong focus on innovation management and value in health. An area of special activity is emerging technologies and their implementation to further advance quality and safety of patient care and self-health management. She is a member of the University Council of the Technical University Dresden and the University of Applied Sciences Fulda, the Scientific Advisory Board of the Private Excellence Initiative Johanna Quandt, the GEOMAR Board of Trustees and chairs the LBG scientific advisory board. She served as a member of the scientific commission and medical committee of the German Council of Science and Humanities, the Senate of the Helmholtz Association of German Research Centers, the Supervisory Boards of the University Hospital Düsseldorf, the Technology & Start-up Centre Oldenburg and the TRON Translational Oncology Mainz, the Council of the Institute for Information Technology (OFFIS) and chaired the shareholder meeting Hearing Aid System Technology. She received her medical degree and doctorate from the University of Freiburg, graduated in Business Administration and Management in Health Care from the University of Mannheim/Heidelberg and completed a Research fellowship in Molecular Biology at the MGH, Harvard Medical School. She was trained in Internal Medicine with a specialization in Gastroenterology, acquired special qualification in emergency medicine, nutritional medicine and radiation protection, and headed the Molecular Biology Research Laboratory with a focus on GI Oncology at the University Hospital Marburg, where she holds an extraordinary professorship. She is the author of numerous international and national publications, invited lectures and review activities.
Axel Paeger, M.D., has served as CEO of AMEOS Hospital group since 2003. Prior to his current position, Dr. Paeger was chief managing officer of Asklepios Kliniken GmbH. Before that, he was a member of the Pacific Health Corporation, Inc. board. He has also served as an associate partner for Health Care Consultancy in Cleveland, OH, USA. AMEOS is among Europe's leading healthcare service providers and primarily serves German speaking regions (with today 83 facilities in the fields of hospitals, long-term me
Bart de Witte hails from Antwerp, Belgium and lived in Brussels, Zürich, Vienna before calling Berlin his home in 2016. He is an inspiring and award winning digital health tech leader. He is the founder of HIPPO AI, an NGO that focusses on Open Sourcing Medical AI, and the founder of the DHealth Academy based in Berlin. He is part of the founding faculty of the European Institute of Exponential Technologies and Desirable Futures, futur.io. An institute that focusses on finding alternative European strategies for this current post-modern era and creating new methodologies for opening up chinks between the diverse possibilities and preferences for more ideal futures offering a greater social benefit. With his mission to use technology for the greater good, Bart has been on a mission to harness the power of artificial intelligence to help to solve current and future inequalities in healthcare. He wrote his first paper on Artificial Intelligence in 1989 while he was on grammar school, and restated his interest in 2010, while working for IBM. His experience and his vision places him in a unique position to deliver research-based, entertaining, inspirational keynotes around the topic of Artificial Intelligence in Healthcare.
Arno M. Roßlau, MD, is a retired general of the German Armed Forces Medical Corps. In the wake of his military career he was educated in all disciplines of military medicine, especially in leadership on the level of general staff. In all his missions, which he was responsible for, he followed his knowledge to a comprehensive degree. He is highly educated in planning, strategic and conducting of operations of German MOD for medical national and international missions. At last, he was the commander of GERMAN Medical Command I, in KIEL. His task was to support all out of area missions between 2002 -2008. He temporarily joined the Headquarters of NATO, EU and UN for missions in IFOR/SFOR Bosnia, UNSCOM Irak, UNTAET Osttimor and other special missions as Medical Advisor. His extraordinary profession involved strategy and the conducting of operations.
Dr. Atala is the Director of the Institute for Regenerative Medicine, and Chair of Urology at Wake Forest University. He is Editor in Chief of Stem Cells Translational Medicine and BioPrinting. Dr. Atala is a recipient of the US Congress funded Christopher Columbus Award, the World Technology Award in Medicine, the Samuel Gross Prize, the Innovation Award from the Society of Manufacturing Engineers, and the Edison Science/Medical Award. He was elected to the National Academy of Medicine in 2011, and to the National Academy of Inventors in 2014. His work was listed twice in Time Magazine’s top 10 medical breakthroughs of the year. He was named by Scientific American as one of the world’s most influential people in biotechnology in 2015. He also received the Innovator of the Year Award from R & D Magazine in 2016. Dr. Atala has led several NIH working groups and was the Founder of the Regenerative Medicine Foundation. He heads a team of over 450 researchers, and twelve applications of technologies developed in his laboratory have been used clinically. He is editor of 14 books, has published over 500 articles and has applied for or received over 250 national and international patents.
Anton is Manager of Pioneers Discover, the consultancy arm at Pioneers. A technology enthusiast specialising in helping corporates achieve their innovation goals through open innovation and intrapreneurship, he has experience organising and planning hackathons, innovation workshops, accelerators and startup-corporate collaboration programs. In the past 5 years he has built up a team of 20 people in the headquarters in Vienna and has consulted a large number of international clients such as Merck, Roche and BBraun.
The graduate business economist and business information scientist earned his doctorate in the field of health sciences. He holds a Master of Laws degree with a focus on data and consumer protection on the Internet. He taught at the Protestant University in Nuremberg, Faculty of Health and Nursing, and since 2008 at the FOM, University of Economics and Management in Berlin and Nuremberg, including health economics. Over the past 20 years, he has gained sound experience as a manager, managing director and board member in top companies in the management of complex IT projects, in the introduction of card- and online-based payment systems and in the successful restructuring and reorientation of companies. Until mid-2015, he was Managing Director of gematik, Gesellschaft für Telematikanwendungen der Gesundheitskarte mbH, and implemented the turnaround of the largest European eHealth project. Prof. Dr. Elmer has headed the "Digital Health Research Group" at FOM for several years. Together with other eHealth experts, it initiates research projects and publishes specialist publications on current developments in the field of digitisation in the healthcare sector. The range of services also includes the organisation of events and active participation in congresses. Naturally the results and experiences from the interaction of theory and practice flow into the project of the INNOVATION HEALTH PARTNERS as well as into the teaching activity at the FOM.
Anna Vonnemann studied biology and is a painter. For many years she worked as an illustrator and consultant for medical drawings for companies such as Johnson&Johnson, Beiersdorf, Waldemar Link and Thieme Verlag. After her two-year-old daughter, Dindia Gutmann, was diagnosed with "hemiparesis" after a stroke, she began to deal with this topic and developed a therapy program together for her daughter. This consists on the one hand of a special gait training and on the other hand of a biofeedback device which imitates the control mechanism of the movement control and is used to improve the disturbed proprioception of the hemiparesis patient. She now has 27 years of personal experience with hemiparesis. In 2014, she founded ReMoD to advance the experience and success she has gained with her daughter and make it available to others.
Dr. med. Anke Diehl, M.A. is Digital Change Manager at the University Medical Center Essen and responsible for the implementation of innovative projects within the scope of the Smart Hospital's digitization strategy. As a physician, she has worked clinically and scientifically in neurology, psychiatry, neuroradiology and radiology. After a part-time Master's degree in Management, she left university medicine for more than eight years and worked for the subordinate department of the North Rhine-Westphalian Ministry of Health, where she headed the Department of Supply Structure Development at LZG.NRW from 2012 to February 2018. She is a board member of SMITH (MII), an expert on the Medical Advisory Board for the development of the telematics infrastructure in NRW and spokesperson for the working group "Digitisation and Personalisation" of the Medical.NRW Cluster.
Anne Schreiter is Executive Director of the German Scholars Organization (GSO), a non-profit that advocates for researchers and scientists, offering programs and training for academics to build impactful careers – in academia and beyond. Anne studied Communication in Social and Economic Contexts at the Berlin University of the Arts and Chinese Language and Culture in Nanjing und Shanghai. After her PhD in Organization Studies and Cultural Theory at the University of St. Gallen in Switzerland, she spent a year as postdoctoral researcher at the University of California at Berkeley.
Dr. Andreas Tecklenburg became member of the Board of Directors and CEO of the Medical School of Hannover (MHH) in 2004. Prior to his position at the MHH he worked as Executive Director at the Sana Clinics Corporation, a large private hospital operator. He was in charge of over 60 clinics with respect to medicine, processes, IT, structure and technology. Dr. Tecklenburg gathered his first experiences as Executive Director in three clinics of the Ostholstein Clinic GmbH in 1996. He is trained specialist in Anaesthesiology. Since 2004, he has been a member of the executive board for the health care department of the Hannover Medical School, and at the same time vice president of the university. Since 2008, he has also been the director of the Institute for Applied Hospital Management (ISAK). He is a member of the board of the Association of University Directors and a member of the supervisory board of the University Hospital Ulm.
Board certified surgeon FMH, SGC), general practitioner, sports physician, rescue physician, and acupuncturist. Owner bragapraxis in Giesshübl: Surgery, pain treatment, GP and acupuncture. Co-founder and CMO of eedoctors: Smartphone app based medical video-teleconsultation service. Owner of the consulting company bragamed GmbH, specialized in telemedicine, eHealth, basic and emergency health care, military and catastrophe medicine, as well as strategic healthcare management. Consultant and expert for the „Hauptverband der Sozialversicherungen“ (association of the social security providers) in Austria for the implementation of telemedical consultation (triage). Associate professor for Telemedicine at MedUniWien, University for Applied Sciences St. Pölten and University Zürich. Peer reviewer of numerous bachelor and master thesis in the telemedical / eHealth field. Associate professor for military and catastrophe medicine, MedUni Zürich. Author of various articles and book chapters on „telemedicine“. Vice-president TelmedAustria. Vice-president of the Swiss Society for Telemedicine and eHealth (SGTMeH). LtCol in the Army Medical Force (staff of the GenMjr of the Swiss Army Medical Corps).
Dr. Andreas Mauroschat is a partner and heads the German practice group Labour Law, IT/Data Protection and Compliance of the international law firm Ashurst LLP. Andreas Mauroschat advises German and international clients on all current labour, occupational pension and data protection issues. One of his main areas of expertise are complex data protection projects in an international environment, for example the outsourcing of data processing processes and international data transfer concepts within corporate groups. Andreas Mauroschat regularly conducts compliance investigations for clients, often in connection with fraud investigations or data protection violations. In addition, he has many years of experience in the employment law support of M&A transactions, in- and outsourcing measures and corporate restructurings. Andreas Mauroschat advises renowned German and international companies in the financial industry on the structuring of remuneration systems in a regulated environment. He has many years of consulting experience in the USA and Great Britain and regularly advises on cross-border transactions that require legal expertise in these two countries. Andreas Mauroschat's team specialises in all legal aspects relating to IP/IT, new technologies and data protection, both transactional and ongoing. Our lawyers have particular expertise in advising companies on complex IP/IT projects, including outsourcing transactions, IT contracts, software licences and data protection issues. They also have particular expertise in e-commerce-related issues and advise clients on the development and implementation of new technologies. Andreas Mauroschat also advises companies, management boards and supervisory boards on compliance and corporate governance as well as on employment and data protection law during internal investigations.
Born on January 2, 1963 in Los Angeles, USA; Roman Catholic; married; two children. His childhood spent Ullmann in Los Angeles until he moved in 1972 with his family back to Germany. After graduating from the Reichenbach High School in Ennepetal in 1981, he studied human medicine at the Ruhr University Bochum and graduated in 1987 with the medical state examination. During his time as an assistant physician at the University Hospital at St. Josef Hospital in Bochum, he participated in clinical training at St Clare's Hospital / Spellman Center in New York City in the area of HIV / AIDS. Since 1995 he worked at the University Clinic Mainz. He trained as an infectiologist at Harvard Medical School from 1996-1998. He habilitated in 2008 in the Mainz University Medical Center and followed in 2012 a call to university professor at the University Hospital Würzburg. Ullmann is section spokesman for infectiology at the BDI (professional association of German internists) and assessor in the working group infections in hematology and oncology of the DGHO. Since 2015, he has been a lecturer at the Friedrich Naumann Foundation for Freedom.
Ananya is a lawyer turned entrepreneur turned innovation specialist. At Invest India, she heads the commercialisation vertical for AGNIi, the national innovation initiative of the Office of the Principal Scientific Adviser to the Government of India. Previously, she headed the expansion drive for the world's largest women-tech startup, Sheroes, into South East Asia. Prior to Sheroes, Ananya co-founded Just Move, an award-winning health-tech startup which she then led to exit in 2016. She began her career with international law firm Clifford Chance LLP in London, with stints in Singapore and Abu Dhabi. Ananya is an alumnus of Stanford University's Institute for Innovation in Developing Economies and National Law School, Bangalore. She has lived and worked in 8 countries
Andrea Egbringhoff has made it her mission to combine ideas, information, and competencies across various emerging technologies. In 2017, she founded a Blockchain community that links EY colleagues from all departments to promote a holistic view of new business models. She is particularly interested in Identity Proof Use Cases, and the NFC chip in her hand makes her a subject of experimentation. Driven by the desire to learn more she has lived so far in 5 different countries, founded a startup, worked as a self-employed innovation consultant and works currently at the Technology Advisory of EY.
Amit Kumar Jain is a business transformation leader and entrepreneur. Under his leadership, over 20+ years of professional career, his organisations have achieved new heights in markets worldwide. He has brought cultural changes, is known for business creation & innovation and is adept at putting technology to a deep purpose. Amit is an Active Change Agent in accelerating digital transformation and driving innovation in Germany while forging Indo-German exchange. He is deeply motivated to solve critical healthcare problems, combining his experience with technological advancements in recent decades. With a credible reputation in Germany and India, and as a pioneer for ideation and innovative outlook, he continues to serve as a guiding force for the conglomerate and society at large.
Dr. Anastassia Lauterbach, has served as director of Dun &Bradstreet since 2013, and is member of the Nomination and Chairwoman of Technology & Innovation Committee. Anastassia serves as a Chairwoman of Censhare AG, a private European marketing technology provider. She serves on the board of Wirecard AG, a global Financial Services provider and easyJet, an airline based in the UK, where she is member of the Audit Committee. Anastassia is member of the Advisory Council Next Generation Directors for Nasdaq and of the Diligent Institute of Corporate Governance. Anastassia serves on the advisory boards of the Ocean Protocol, a private global blockchain infrastructure and IP company, Cogitanda AG, a private European cybersecurity insurance broker and TM Forum, a non-profit global Association of Telecommunication Companies and their vendors. She is Fellows of the Salzburg Global Seminar. Previously, Anastassia served as SVP Europe at Qualcomm, a world leader in wireless technologies, from 2011 to 2013. She served at Deutsche Telekom AG, an international telecommunication provider, as SVP business development and investments from 2010 to 2011. She was acting Products and Innovation Officer from 2009 to 2010. During her time at Deutsche Telekom she additionally served as a member of the Executive Operating Board. Prior to Deutsche Telekom she served as Executive Vice President, Group Strategy at T-Mobile International AG from 2006 to 2010, and prior to T-Mobile, she served from 1996 to 2006 in various operational and strategic roles at Daimler Chrysler Financial Services, McKinsey & Company and Munich Reinsurance Company. She is Chief Executive Officer and founder of 1AU-Ventures and currently advises several U.S. and European based AI and cybersecurity companies and Investment Funds, e.g. Evolution Partners and Analytics Ventures. She is Senior Advisor for Artificial Intelligence at McKinsey & Company. She trains boards in cybersecurity and cognitive/ AI and robotics related technologies and their links to corporate governance. She advises ITU, a United Nations organization, on AI policy and governance. She is leading author in “Artificial Intelligence Imperative. A Roadmap for Businesses”. The book was published by Praeger in April 2018. Anastassia contributes several chapters to the book on Artificial Intelligence and Law by the American Bar Association, which will be released in Summer 2019. Anastassia contributes a chapter on Cognitive Science and Cognitive Computing to a Volume on Cognitive Computing by Apple Executive Series, to be released in late 2019. Anastassia has a PhD in Linguistics and Psychology.
Alexandra started a blog to deal with the situation, motivate others and raise awareness, as cancer is still a taboo. Negligence does not protect though and she promotes regular self examinations, as breast cancer isn’t exclusively for the generation 60+ and incorrect diagnosis amongst young patients happens still too often. Her newest project is a podcast (2 Frauen, 2 Brüste - 2 women, 2 bosoms), which she runs with her fellow breast friend Paula Ellerbrock, covering several topics around cancer, like finances, chemos and administration. They are aiming to lift the tabu and in abreeze talk about the highs and the lows without trivializing it, as it is a life threatening disease.
Alexandra Marisa has felt very much at home in theatre, television, and dubbing studios alike. Her voice is known to millions in German speaking countries: Giving her voice to Eva Green in James Bond ‘Casino Royale’, as well as Miranda Otto in the ‘Lord of The Rings’ trilogy, Charlize Theron in ‘Devil’s Advocat’ or Kate Winslet in ‘Heavenly Creatures’ by Peter Jackson. Children’s ears love her voice as `Pocahontas` in the famous Disney film, as Nala in ‘The Lion King’ and Mama Imelda in Disneys Blockbuster 2017 `Coco` as well as in the audio book series ‘Bibi Blocksberg’. She has also acted in various TV productions and starred as female lead in several German feature films („Rotlicht - In der Höhle des Löwen","Im Dickicht der Großstadt", "Doppelpack" and others).
Dr. Alexander Schachinger, founder/ceo of EPatient Analytics GmbH, a market intelligence company for the digital healthcare market focussing on digital patient target groups, market scenarios and evidence-based practice. Alexander studied media economy in Berlin/Toronto, followed by a career in global med. companies and digital strategy consultancies. 2014 he finished his phd on the digital patient in Germany.
Alexander Ehlers provides leading health care corporations with comprehensive advice on all legal and strategic matters, in particular national and international pharmaceutical companies and manufacturers of medical devices. The counselling comprises all questions relating to health policy and social law as well as issues of reimbursement of expenses for medical services and drugs/medical devices and market access of pharmaceuticals. He is highly renowned for covering the complete spectrum of medical law, especially in terms of policy-making within federal healthcare legislation, but also forensic case management. Owing to his many years of work in the German health care system, Alexander Ehlers disposes of contacts with relevant decision-makers, which is regularly used by clients within the scope of public policy advisory. Alexander Ehlers is a frequent speaker at specialist congresses and the author of numerous publications.
Economist and philosopher Agnieszka Krzeminska [agn'jeʃka kʃem'inska] is specialized on digital technology development and it's social adoption and implications. From 1996 she developed the Siemens Automotive Intranet and worked thereafter for big internet agencies. Since 2009 she runs her own agency Social Media Führerschein for Social and Digital Media Consulting and Strategy. Her customers include, among others, MOPO, Mediengruppe DuMont, Autovision, Carlsen Publishing and many more. She carries out research and teaches at the Leuphana University of Lüneburg as well at the University of Applied Sciences (HAW) in Hamburg in the realm of Digital Media and Cultures and has spoken at many scientific and business conferences worldwide. In addition she is the co-founder of the women’s business network Digital Media Women, organiser of the Quantified self Meetup in Hamburg, as well as advisory board for the yearly Social Media Week conference in Hamburg.
Adebowale Daniel Bakare is a dynamic banking and finance professional with several years of experience in various management and planning position in Nigeria. He studied Agricultural Economics from the University of Ibadan, in Nigeria. He was also trained as a Project Manager in Development Cooperation in Germany, after which he worked briefly with the German African Business Association, where he was part of the team that successfully organised a couple of International Agribusiness and Finance Events. Earlier in 2019, he was appointed Country Leader, Innovate Africa Germany, where he is currently evaluating the possibilities of combining the trio of Agribusiness, Healthcare and Power as a means to empower the teeming African populace.
Achim Schütz currently works as clinic manager at Capio Elbe-Jeetzel-Klinik and as business consultant in the field of A.G.I.L.E. management / systemic leadership, controlling and strategy development. Before joining Capio, he worked as hospital manager and head of finance in hospital associations. Mr. Schütz is a qualified business economist, accountant, insurance businessman and has completed additional training as a certified systemic coach and mental coach (certified according to DGCO - Deutsche Gesellschaft für ganzheitliches Coaching) as well as a medical and psychotherapeutic hypnotherapist at the Centre for Applied Hypnosis. He has many years of cross-industry specialist and leadership experience. He is the author of various specialist articles and a specialist book on the subject of systemic leadership. ("Leadership and guidance - systemic solution-oriented options for action")
Throughout his career, Dr. Grossmann has focused on tapping the paradoxical power of technology to coexist with a better, more humane medical care. As a healthcare futurist, being a full-time practicing surgeon gives him the rare skills, qualities and advantages to combine and enhance both his passions. He is one of the earliest Google Glass explorers and in June 20th, 2013, was the first doctor to ever use Google Glass during live surgery (Currently focusing Spatial Computing, on MagicLeap and Hololens applications in Healthcare & Education) Being a telemedicine, Global Health and Digital Medicine advocate, Dr. Grossmann is a strong believer in the power of technology to augment healthcare and education, to better connect providers and patients. He is convinced that innovation in healthcare technology, along with the current developments in Mobile and Wearable platforms, Virtual, Augmented and Mixed Reality, along with AI, Deep Learning, Blockchain, Nanotechnology, 3D printing and Robotics will exponentially improve healthcare connectivity, communication and data management, and result in more efficient, intuitive, less expensive and ultimately better and more empathic patient care and Medical Education, as well as improved Global Access to Healthcare.
Senior Indian Diplomat, India
Ambassador Gurjit Singh is a senior Indian diplomat with 37 years of experience. He has been the Ambassador of India to Germany, Indonesia and ASEAN and Ethiopia and the African Union besides having been in in Japan, Sri Lanka, Kenya and Italy on assignment. He has authored four books the last of which was Opportunity Beckons: Adding Momentum to the Indo-German partnership which focused on how India and Germany can diversify and intensify their relations in a globalizing world as good partners.
He frequently contributes on economic, developmental, strategic and trade issues to various journals and books. He has an abiding interest in developmental economics and issues of sustainable development. He is an Honorary Professor of Humanities at the Indian Institute of Technology (IIT), Indore. He Chairs the CII business Task Force on Trilateral Cooperation in Africa.
John is a thinker entrenched in the world of science, medicine and innovation. John is the founder of NOSTALAB—a digital health think tank. He’s currently ranked as the #1 global influencer in digital health and generally regarded as one of the top global strategic and creative thinkers in this important and expanding area. He is also one the most popular speakers around the globe presenting his vibrant and insightful perspective on the future of health innovation. His focus is on guiding companies, NGOs, and governments through the dynamics of exponential change in the health / tech marketplaces. Unwilling to accept the status quo, he’s a contrarian with a sharp focus on the future. A leading voice in the convergence of technology and health, Nosta helps define, dissect and deliberate global trends in digital health. He is consistently ranked among the top names in almost every digital health list and has sustained that position for several years. Beyond simply an influencer, John is also defined as “most admired” to “top disruptor” in technology, innovation, life sciences and the pharmaceutical industry. He is also a member of the Google Health Advisory Board. Further, John is also a frequent and popular contributor to Fortune, Forbes, Psychology Today and Bloomberg. In 2018, he received a PhD, honoris causa from Udabol Internacional: Oficial Universidad de Aquino Bolivia and from the Latin America Foundation, University of Science and Informatics Peru and Centre for Neuroscience. He was also awarded the diploma of honour from the Bolivian government for his work in health technology in promoting innovation and engagement around the world. John has an established reputation as a vocal advocate for strategic thinking and creativity. He has built his career on the “science of innovation,” a process where strategy and creativity work together to create inflection points in the market. He has also been recognized for his ability to translate difficult medical and scientific concepts into material that can be more easily communicated to consumers, clinicians and scientists. Additionally, John has distinguished himself as a scientific thinker. Earlier in his career, John was a research associate at Harvard Medical School and has co-authored several papers with global thought-leaders in the field of cardiovascular physiology with a focus on acute myocardial infarction, ventricular arrhythmias and sudden cardiac death. John cut his teeth at the "big"; agencies including Ogilvy CommonHealth, where he has held a series of positions including Chief Creative Officer, Chief Strategic Officer and unit President.
Breast cancer is 99% preventable with early detection. That's why Carman Kobza created India’s first viable Breast Health Education & Digital Screening program. Born and raised between the Czech and German immigrant settled farming communities of Praha and Freyburg, Texas, Carman led an international executive career with travels to over 80 countries. He founded a women’s focused digital diagnostics company in Bengaluru in 2015. With an efficient yet personalized “We Come to You” approach, Carman exerts full passion to end an unconscionable world affliction – Needless Breast Cancer. LADY B WELL – THE BREAST HEALTH PEOPLE launched to rapidly expand the reach and impact by offering a welcoming, certified & de-stigmatized women’s health experience.
Dr Borisch is an MD and a Histopathologist, MPH and Fellow of the Royal College of Pathology (UK). Her scientific research work delves into neoplastic lesions of the immune system and breast cancer. Her interests also include community-based oncology, as well as health communication and global health. She is the Editor in Chief of “Pathobiology” and the Co-Editor of “Journal of Public Health Policy”. In addition to her academic work she acts as the Director of the World Federation of Public Health Associations and holds positions at several Committees of Public Health oriented institutions. She was president of Europa Donna – The European Breast Cancer Forum – and Founding President of the Swiss Forum of Europa Donna. She teaches at the University of Geneva, the Swiss School of Public Health and she also teaches patient support groups. She is author of over 120 scientific papers and 2 books.
Brian de Francesca is a Johns Hopkins educated expert in the use of digitalization and connectivity to improve healthcare quality, access and efficiency. Brian was first exposed to this world with the success of the world’s first tele-radiology program in his home town of Baltimore, Maryland at the Veterans Administration Medical Center. He was also involved with the U.S. Chamber of Commerce e-commerce IBEX (International Business Exchange) project and conducted the some of the first pilots of Digital Pathology. His company participated in the “Whole System Demonstrator Project” in the U.K., which was the largest randomized control trial of telehealth and telecare in the world. Brian maintains a full roster of international speaking and writing engagements, covering a wide array of healthcare topics and most recently appeared on the cover of the July issue of “Middle East Medical” magazine. Brian has over 20 years international healthcare experience. He later worked for Johns Hopkins in Abu Dhabi, where he was responsible for a wide network of healthcare facilities. It was during this period that he refined his vision for a Virtual Healthcare Service Platform, which eventually became Ver2. He is an advisor to :IRYO – a European company that is developing one of the first cloud-based electronic health records, incorporating a full Blockchain technology foundation. Brian is also an active member of The World Future Society. In 2015, Brian founded Ver2 – an innovative telemedicine services platform, that was the first company in the world to successfully use Blockchain to support tele-medical education. One of Brian’s personal goals, is to connect 700 refugee camps to healthcare and education resources over the Ver2 Platform. Brian is a graduate of Johns Hopkins and Loyola Universities, a Fellow of The Advisory Board Company and holds a Certificate in Company Direction from “The Institute of Directors” (IOD). Brian presently resides in Dubai, UAE.
Bruce is the Founder & Managing Director of The Arcady Group, LLC, a consulting company that helps organizations and businesses address global health issues and improve patient health outcomes by addressing key challenges in patient care and disease management. Bruce is both a consultant to, and grantee of, the Bill & Melinda Gates Foundation, where he leads the development and scale-up of new approaches to improve medication adherence and support differentiated care for TB and HIV patients in China, India, and Sub-Saharan Africa. Bruce also is a Senior Adviser to the Medicines for All Institute, a Virginia-based organization that uses novel chemistry approaches to dramatically reduce the cost of, and thus improve access to, a wide range of HIV, TB, and malaria medications. Finally, Bruce also advises Novartis Pharmaceuticals’ Digital Medicines team – helping bring health outcomes-enhancing digital tools to patients, doctors, and nurses around the world. Previously, Bruce was President of MeadWestvaco Healthcare, part of a $7B global packaging company serving the pharmaceutical and related industries. Bruce lives in Richmond, Virginia and in Guiting Power, England with his wife, Julie. Bruce’s two daughters, Maggie and Charlotte, now live and work in Washington, DC, USA.
Bernd Altpeter studied business administration in Germany, France and the USA. He has been working in the e-health and telemedical field since 2006; previously, he served as a consultant for numerous companies in life sciences e.g. as Partner of the Management Consulting Company Monitor Group as well as founder of the Driving Growth Group. From December 2014 to 2016, Bernd Altpeter held the role of President International at Physicians Interactive USA. In 2016 Bernd Altpeter started the Digital Health Group including the German Institut of Telemedicin and Health Promotion, Medulife – a Health IT company and Best Care Solution a company for integrated management contracts.
Bastian Hauck is a strategic business consultant with 10+ years of experience in co-creating patient-centric engagement strategies in digital health. He is the founder of #dedoc°, a network of independent diabetes patient advocates across Europe. #dedoc° translates the idea of traditional peer-to-peer support in chronic diseases to the online world, using social media and blogs to create authentic, self-sustaining patient communities. As keynote speaker and diabetes advocate, Bastian promotes taking the patient voice seriously. He serves on the board of diabetesDE – Deutsche Diabetes-Hilfe, is a director with the International Diabetes Federation and co-leads The OPEN Project, a patient-driven, EU-funded consortium conducting research on Do-It-Yourself Artificial Pancreas Systems (DIYAPS) and the #WeAreNotWaiting movement.
Dr. Benedikt Zacher is managing director of pflege.de, Germany's leading consulting platform for all topics relating to living and living in old age. Before founding pflege.de, Zacher worked for 7 years at the international consulting group Altran, initially as Business Development Manager, before assuming responsibility for a global business unit in numerous European countries as well as in Brazil, India and China in 2008. For Altran, Zacher developed key accounts for the medical technology and pharmaceutical industries such as Siemens Medical, GE Healthcare, Philips, Wavelight, etc. In 2010 he had the idea for pflege.de together with his co-founder Lars Kilchert. pflege.de is supported not only by many associations and self-help organisations but also by the Honorary President of the German Nursing Council, Marie-Luise Müller. Dr. Zacher is also involved in the "Verband für häusliche Betreuung und Pflege e.V." as honorary chairman of the board.
Since the end of 2017, Bernadette Hosters has been working as a nursing scientist in the Nursing Development and Research Unit at the University Hospital of Essen, which she has lead since March. She has clinical experience in health care and nursing as well as bachelor's and master's degrees in health and nursing science (M.Sc.). Within the scope of her current activities, Ms. Hosters is significantly entrusted with the nursing projects of the "Smart Hospital" initiative, which was launched at the end of 2015 for all areas of the Essen University Hospital. In addition, she represents the University Hospital of Essen in the nursing research network of the VPU and works as a lecturer at universities and educational institutions in the healthcare sector.
Chenchao, born in China, has been in Germany since 2002. He is the Founder of Silreal, a consulting firm enabling companies to enter, expand and find strategic partners in China and Europe. Capitalizing his extensive insights about China and its interrelations with Europe, Chenchao combines his expertise in healthcare and his intercultural competencies to enable institutions to succeed with the Belt and Road Initiative. As a Global Shaper of World Economic Forum, Chenchao is regularly invited as speaker and guest at international conferences such as German Federal Foreign Office, G20 Global Solutions Summit, OECD Forum, The Federation of German Industries and Max-Planck Society. He studied chemistry at the Technical University Munich and was interviewed by the New York Times.
Dr. Sen’s program is interested in tissue injury and repair. His group works across small animals, large animal model to human and patient-based research. In the brain, specific focus is directed towards stroke biology and related neurodegeneration. In a 2017 publication in Nature Nanotechnology, the Sen Group reported successful tissue reprogramming in vivo and use of skin-derived reprogrammed neural cells to rescue the stroke-affected brain. Dr. Sen’s laboratory has concluded Phase I and Phase II stroke clinical trials and is currently planning a Phase III stroke trial testing the tocotrienol form of natural vitamin E. Almost two decades ago, Dr. Sen reported that the tocotrienol form of natural vitamin E is orders of magnitude better than the widely known tocopherol form of vitamin E in protecting neural cells and the brain tissue. This line of work progressed from rodent stroke to canine stroke to clinical trial. Dr. Sen’s work is cited 25,000+ times in the literature. At present, he is cited more than 2,000 times annually and has an H-index of 83.
Cécile is a physician working in a pediatric emergency room department in Paris, as well as Medical Director for iLumens, a university department of the Paris Descartes Medicine Faculty, specialized in innovative teaching methods in healthcare through new technologies and simulation. At the beginning of 2015, she founded Eppocrate, an NGO devoted to bridging the gap between the French physician community and the digital healthcare ecosystem.
Prof. Dr. Filipe Castro Soeiro is a senior international academic and executive leader, professor and researcher, with 15+ years of experience and deep understanding of the for-profit higher education, education technology, corporate knowledge management and executive training sectors, and 25+ years of international experience as senior corporate executive in multiple technology, industry, market and business life cycles. He is an international scholar and expert in digitization strategy, innovation, technology monitoring, digital business, digital marketing and digital transformation in the industry 4.0, including the fields of smart cities and urban planning, telecommunications and networks, e-commerce, fintech and machine learning, cleantech, energy, biotech, digital health, regional innovation ecosystems and global supply chains, smart factories, project management and business consultancy. He is well experienced in leading start-up, transformation and growth of higher education and business organizations, projects and teams in Europe, China and U.S. and is an avid learner, holding five degrees and three post-graduation programs in different fields. He is a strategic advisor and a change maker, who is market driven, oriented to results, and brings to an organization the ability to bridge strategy, business, academic and research.
Since 2014 Chairman of the Executive Board and Medical Director of the Rostock University Medical Center; previously Managing Director of the Clinics of the City of Cologne gGmbH and Medical Director of Mühlenkreiskliniken, Minden, as well as Head of Corporate Development at the University Medical Center Schleswig-Holstein; Specialist in surgery.
Chris Lawer is the founder of Umio and the author of Health Ecosystem Value Design®: Value Sensing, Exploration, Strategy and Co-Creation Framework. Umio evolved from Chris' thirty years spent advancing innovation thinking, co-creation, system-level design and customer-focused strategy. In this time, he has interviewed and engaged with thousands of patients, clinicians, policymakers and other health ecosystem actors all around the world. An alumni of Cranfield School of Management, Chris was awarded the honorary position of Senior Fellow at UCLA Center for Healthier Children, Families and Communities in 2019.
Dipl. oec. Chris-Gilbert König is managing partner of Healthcare X.0 GmbH. He is an acknowledged expert in the field of artificial intelligence and is often represented as a speaker at international conferences focusing on artificial intelligence. The Software products from Healthcare X.0 GmbH optimize the entire organization of the After completing his studies in economics, Chris-Gilbert König worked at a Deloitte subsidiary until he became self-employed in 1995. Since 2015 Chris-Gilbert has been at König exclusively responsible for the healthcare sector. He is a pioneer and co-developer of the Healthcare X.0 product family. PatientAssist, a module of this family, is an electronic health record for patients, in which all relevant information is stored. Deloitte subsidiary until he became self-employed in 1995. Since 2015 Chris-Gilbert has been a König exclusively responsible for the healthcare sector. He is a pioneer and co-developer of the Healthcare X.0 product family. PatientAssist, a module of this family, is an electronic health record for patients, in which all relevant information is stored. Bundle your data digitally. Diseases, medication, medical data and daily updated sensitivities can be digitally stores, views, analyzes, and forwards apps or web applications as required will be. PatientAssist can be operated securely online and thus supports patients and the doctors treating you.
Christian Klose has had a career at the AOK in various positions. Starting with an apprenticeship as a social security clerk and a later specialisation as a health insurance specialist at AOK Berlin, his path led him to regional responsibility as head of the customer service department at AOK Berlin. In 2007, he became a member of the AOK Berlin management team, with a focus on customer service, marketing and sales, corporate and private customer service and dental care. With the merger of AOK Berlin and AOK Brandenburg in 2010, he assumed the role of Managing Director in the newly created AOK Berlin-Brandenburg market management division. One year later, he also took over this role in AOK Nordost, which had emerged from another association with AOK Mecklenburg-Vorpommern. Since 2016, he has been CDO of AOK Nordost and heads the Digital Innovation Management department. He sees himself as a networker, pilot and driver of digitalisation. Mr. Klose pursues the philosophy that the digital transformation of AOK Nordost can only succeed if the human factor is focused alongside digital developments - both internally and externally.
Nothing is impossible — Constantin Wiesener has proven this with an innovative idea from the field of medical technology. The 34-year-old from Potsdam took first place at this year's Speed Lecture Awards at the BIONNALE in Berlin. Within only three minutes he was able to convince the audience of his research work. His goal: to enable wheelchair users to move their legs, such as cycling or swimming, by means of targeted functional electrostimulation (FES). Wiesener studied electrical engineering and audio communication at the TU Berlin. After working as a software developer at zplane.development and Native Instruments and as a control engineer at Berlin Heart GmbH, he has now returned to the TU to work on his doctorate in the field of control systems.
Dr. Feldmann ist biomedizinische Ingenieurin und hat einen PhD in Theoretischer Medizin mit den Forschungsschwerpunkten Telemedizin für Herzpumpenpatienten, Komplikationen wie Blutschädigung oder Infektionen und Modellierung für In-vitro-Tests. In ihrer 15-jährigen Karriere brachte sie eine neuartige Herzunterstützungspumpe als F&E- und Produktionsingenieurin in ein Aachener Start-up-Unternehmen und unternahm preisgekrönte Forschungen zu Oxygenatoren und Herzpumpen, am Institut für Angewandte Medizintechnik der RWTH Aachen. Seit November 2015 leitet Christina Feldmann die experimentelle Forschung des Programms Mechanische Kreislaufunterstützung und Aktive Gerätetechnologien (Direktor: Prof. Dr. J. Schmitto) an der Medizinischen Hochschule Hannover (HTTG, Prof. Dr. A. Haverich).
Christof von Kalle studied medicine at the University of Cologne from 1981 to 1987 and earned his doctorate there in hematology/oncology. He specialized in gene therapy during research stays at Memorial Sloan Kettering Cancer Center in New York and at Fred Hutchinson Cancer Research Center in Seattle, and became group leader of the Gene Therapy Program at the University of Freiburg in 1996. Starting in 2002, he served concurrently as professor of pediatrics and program leader of the Gene and Molecular Therapy Program at Cincinnati Children’s Hospital Medical Center in the United States. In 2005 he accepted an appointment as professor of translational oncology at the German Cancer Research Center (DKFZ), where he played a pivotal role in establishing the National Center for Tumor Diseases (NCT), a joint institution of DKFZ and Heidelberg University Hospital. For many years he served as spokesperson of the NCT’s Board of Directors. Since April 2018, he has also held the position of chief research officer at the Sidra Institute for Women and Children’s Health in Doha, Qatar. On June 1, 2019, Professor Christof von Kalle became a tenured professor of clinical translational sciences at the Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Berlin.
Studied human medicine in Regensburg and Munich (TU); license to practise medicine 1979; doctorate 1981; habilitation 1994. Between 2009-2011, completed a MBA course in health management at Osnabrück University of Applied Sciences. DFG scholarship 1981-1983 at the Harvard Medical School in Boston, specialist training in surgery 1984-1991 at the Technical University of Munich, majoring in visceral surgery (1995) and thoracic surgery (2000). 2001-2018 Director of the Clinic for General, Visceral, Thoracic and Vascular Surgery of the University Medical Center Greifswald; since 2018 full-time Medical Director of the University Medical Center Greifswald.
Dr. Cornelius Glismann has over 20 years of experience in national and international health care business development and operations of medical centers. Dr. Glismann was holding senior positions and consulted leading international companies like CIGNA, Fresenius/ VAMED, Asklepios, Deloitte and Beckman Coulter. Dr. Glismann holds M.Sc. in Industrial Engineering from Technical University of Aachen, Germany and a Ph.D. in Biomedical Engineering from University of Miami, USA. Dr. Glismann is one of the founding partners of CorporateHealth.
Dr. Czuee Morey is a digital health consultant at Wega Informatik helping pharmaceutical and healthcare companies understand the value of digital technologies and employ them in various areas of R&D. Previously, she worked as a market analyst at Debiopharm International in Lausanne evaluating digital health applications in pharma/healthcare and advised senior management on best areas for venture investment. She has also worked as a data analyst for an Indian healthcare app for tracking maternal and child health in low resource settings. She has a PhD from University of Lausanne, Masters from Indian Institute of Technology Bombay and has worked on various research areas in biophysics and genomics.
David Oliva Uribe is currently the Head of the EUA Council for Doctoral Education. His work is focused on global trends in doctoral education, doctoral programmes and researcher career development. Before joining EUA, David worked for 15 years in research and academia in Belgium, Germany and Mexico. As researcher and team leader of a research group specialised in mechatronics, he gained experience in Germany working and establishing industry projects, as well as participating in the preparation and conduction of EU-funded projects in different university environments. His personal research work is on the development of intelligent surgical tools to improve the safety of brain tumour’s operation with focus on the use of tactile sensor technologies. This research work has been conducted in cooperation with German and Belgian partners. David, as a pro-bono activity, has participated the last 10 years in the development of professional networks of highly skilled Mexicans living in Europe to promote academic and scientific cooperation between the European Union and Mexico.
Danielle works to create and promote menstrual health research, education, policy and innovation. Having helped launch and grow International Menstrual Hygiene Day (May 28) in 2014, Danielle is committed to collective impact and thus uses menstrual health as the entry point to addressing and improving female health across the lifecycle. Danielle is the CEO and Executive Director of the Menstrual Health Hub (MH Hub), a female health social impact business in Berlin and London.
Dario Wyss was born in 1984 in Aarau, Switzerland. He studied mechanical engineering at ETH Zurich and received his Masters degree in 2010. He joined the SMS Lab of Prof. Robert Riener in 2010 as a PhD student. His research focuses on rehabilitation engineering, especially on robot-aided gait rehabilitation. These days, Dario Wyss is co-directing the Cybathlon together with Dr. Roland Sigrist.
David Matusiewicz is a Professor of General Business Administration, in particular Health Management, at FOM University - the largest private university in Germany. Since 2015 he has been Dean of the University's Health & Social Affairs department and director of the Research Institute for Health & Social Affairs. In addition, he is a founding partner of the Essen Research Institute for Medical Management (EsFoMed GmbH) and supports start-ups in the healthcare sector as a founder and business angel. Matusiewicz is also a member of various advisory boards and an investor in companies involved in the digital transformation of the healthcare sector. Prior to his professorship, he worked for several years as a research assistant with Prof. Dr. Jürgen Wasem at Alfried Krupp von Bohlen and Halbach-Stiftungslehrstuhl für Medizinmanagement at the University of Duisburg-Essen in the working groups "Health Economic Evaluation and Health Care Research" and "Health System, Health Policy and Drug Control". Until 2017, Matusiewicz also has professional experience in service control in Health Insurance companies (including the company health insurance fund of Thyssen Krupp, among others). Until 2014, he was also Managing Director of Forschungsnahen Beratungsgesellschaft im Gesundheitswesen (ForBiG GmbH) - a spin-off of the Chair of Medical Management.
Dimitrios Tzalis holds a PhD from the University of California, San Diego, a M.Sc. in Chemistry from University of Chicago, and a M.Sc. in Biology from Ball State University, Muncie, USA. After a postdoc at the Philips University Marburg, Germany, he founded Taros in 1999, and has since been active as a serial biotech entrepreneur. As a Project Executive and Head of Chemistry, he led the chemistry activities of the EUR 196 million early drug discovery platform „European Lead Factory“ (ELF). Dimitrios is the author of more than 15 publications and holds 4 patents.
Dennis Grishin is co-founder and Chief Scientific Officer of Nebula Genomics. He studied molecular medicine at the University of Freiburg and computer science at Harvard University. Dennis is currently a Boehringer Ingelheim Ph.D. Fellow in Genetics and Genomics at Harvard University. He has been awarded the German National Academic Foundation Fellowship and named a Forbes 30 Under 30 in Healthcare.
Desiree Dickerson, PhD is a neuroscientist and clinical psychologist who specialises in academic mental health and well-being. Based in Europe, she works with leading academic institutions, lab groups, and academics themselves to curate a healthier approach to research. Desiree graduated with her PhD and a Postgraduate Diploma in Clinical Psychology from the University of Otago, New Zealand. Her PhD research in systems neuroscience used in vivo electrophysiology to explore impaired neural communication in model systems of schizophrenia. She then moved to the Institute of Science and Technology (IST) Austria for a postdoc in systems neuroscience. After witnessing (and experiencing) the unhealthy and counterproductive lifestyles demanded by the academic system and exacerbated by perfection, self-doubt, and uncertainty; she now employees her clinical training to help academics and institutions to navigate the challenges of academia with the goal of creating a research culture where individuals thrive alongside their research.
Dietmar is a neurosurgeon by training and injects entrepreneurial spirit into research. After obtaining a law degree and passing the bar examination in Berlin in 2003 Dietmar went to Charité Medical School. In 2007, he graduated and specialized in the Charité Department of Neurosurgery. He is a certified board member in neurosurgery since 2013. His research focus has been in perioperative imaging and functional diagnosis before founding the research group Simulation-based Prediction of Stroke. For the last 4 years, he has been working on advancing stroke treatment by personalized imaging-based stroke prediction. Funded by several federal grants he has built a strong interdisciplinary team of physicians, software engineers and computer scientists to develop a decision support software that provides risk scoring and treatment planning in stroke. He is currently heading the research group "Predictive Modeling in Medicine" in the Charité.
Douglas Haggstrom leads the DayOne accelerator, an accelerator for digital health companies that uses an ecosystem of experts to build the people, companies and products to improve their chance of impact. He has worked for more than 15 years with large and small companies in the healthcare, media, finance and industrial sectors, helping them think about and execute strategies around growth in Australia, Switzerland and Sweden. He was also the european manager of a Fintech startup for 5 years and has 5 years of experience as a drug development chemist with AstraZeneca. He holds a Bachelor of Applied Science in Industrial Chemistry from the University of New South Wales and a Graduate Diploma in Applied Finance in his home country of Australia.
Dirk Hunstein, Dr. rer. medic, Diploma in Nursing Economics, RN, Managing Partner of ePA-CC GmbH. After training as a nurse and working in the field of haemato-oncology, he has held various positions as EFQM assessor up to head of nursing research/development and later quality management at the Dr.-Horst-Schmidt-Kliniken HSK in Wiesbaden. Accompanying this, he has repeatedly worked as an expert for the German Nursing Council, the Federal Ministry of Health, the German Advisory Board on Gerontology and as a referee on the Board of Consultants of the magazine "Pflege". Also teaching activities at the FH St. Gallen, the Frankfurt University and the University of Witten/Herdecke.
Born 1969, raised, and studied medicine in Berlin, Germany. Devoted trauma surgeon under best conditions at the Unfallkrankenhaus Berlin, and with the help of extraordinarily talented colleagues. Employers allowed for spending time in the lab (Karolinska etc.) and even more time to reach a post-graduate Master degree in epidemiology. After (European) board approval in surgery and trauma surgery, a painful decision was made in favor of research and against the ED doctor's role. The PhD degree and full professorship at the Charité University was subsequently followed by an appointment of the BG Kliniken Group as head of research.
PD Dr. med. Dominik Pförringer is a specialist in orthopaedics and trauma surgery at the Klinikum rechts der Isar at TU Munich, where he researches and develops the field of digitisation and process optimisation. He is the initiator and organizer of the annual congress "Digital meets Clinical Healthcare" and the quarterly meeting "Digital Healthcare Entrepreneurship". Since his full-time MBA studies at INSEAD in Fontainebleau and Singapore, he has worked as a management consultant and advisor in the areas of private equity and venture capital, and also advises and supports healthcare start-ups. He also gives regular lectures on entrepreneurship for medical students and the TUM School of Management.
At Proximie, Ed has helped create an AR collaboration platform that allows doctors to remotely transport themselves into any clinical setting, anywhere in the world. By overlaying a live video feed with rich augmented reality content, Proximie aims to provide safe, accessible and cost effective surgery to patients globally. Proximie has enjoyed success with early adoption by major medical institutions and NGOs and has won multiple awards including Foreign Press Association Science Story of the Year. Ed enjoys collaborating with innovators from different countries and specialties on bringing the benefits of this technology to the wider population.
Drew Berry is a biomedical animator who creates beautiful, accurate visualisations of the dramatic cellular and molecular action that is going on inside our bodies. He began his career as a cell biologist and is fluent navigating technical reports, research data and models from scientific journals. As an artist, he works as a translator, transforming abstract and complicated scientific concepts into vivid and meaningful visual journeys. Since 1995 he has been a biomedical animator at the Walter and Eliza Hall Institute of Medical Research, Australia. His animations have exhibited at venues such as the Guggenheim Museum, MoMA, the Royal Institute of Great Britain and the University of Geneva. In 2010, he received a MacArthur Fellowship “Genius Grant”.
Eberhard Scheuer is Chairman of the Health Information Traceability (HIT) Foundation, whose aim is to promote the digitization of health data in order to improve the exchange of information between healthcare stakeholders. His main interest is the use of blockchain technology in healthcare. He is also the founder of the Digital Health Forum, the leading Swiss conference on digital health, as well as managing director of the Swiss Digital Health Association (SVDG). He has been a lecturer on eHealth at the University of Zurich since 2006. He came into contact with this topic 20 years ago as a psychologist and then as head of Medical Online Consultancy Service at the University Hospital in Zurich.
Eileen is a multimedia journalist, trained media trainer and editor of Achilles Running, one of the largest running websites in Germany. The passionate runner and audio lover has worked for various radio stations such as NRW Lokalfunk, 1LIVE and Deutschlandfunk Nova, where she specialises in gaming, apps and digital trends. She has also worked as a podcast editor for companies such as Lufthansa and Deutsche Telekom. In 2016 she won the LfM radio award for the series "Eine Woche ohne Plastik" (one week without plastic).
Emily Sheldon is most passionate about using market-based approaches to solve complex challenges throughout the African continent. She serves as co-founder and CEO of the African Health Innovation Centre (AHIC), a Ghana-based NGO dedicated to engaging diverse stakeholders to improve health outcomes. AHIC implements programming in Ghana and beyond – infusing innovation and entrepreneurship into traditional health delivery, creating connections at the community and system levels, and empowering a new generation of thought leaders and action takers. Emily holds a Master of Public Health from the Vanderbilt University School of Medicine and specializes in process leadership, project management, and strategy.
Eileen has seven years of experience working in the start-up and social entrepreneurship space in Europe, Asia and Africa. She works as an advisor to the German Indian Startup Exchange Program (GINSEP). Before returning to Germany, she worked as a project manager for a project on corporate engagement in start-up incubation and as an advisor on innovation promotion in MSMEs for GIZ in India. Eileen has a Bachelor in Business Administration, Political Science and Public Administration and graduated as a Master of Science in Marketing from Berlin Institute of Technology. She has also worked as a research assistant for Fraunhofer, one of the leading research institutes in Europe for applied science, on topics such as Knowledge Management, Cluster Development and Innovation. Eileen has gained substantial international experience while conducting assignments in Asia, Africa and Europe for various clients such as GIZ, the German Startups Association and the Bertelsmann Foundation.
Elisa works at the epicenter of the Berlin digital and future health innovation scene, collaborating, connecting and co-creating with organisations and companies of all sizes in Germany and across Europe, and helping them develop their innovative ideas and technologies in health and care and accelerate them to market, all with patients at heart. An agent of change with a visionary mind, Elisa’s passion is to improve quality of life and bring affordable healthcare to underserved populations. Using Umio Health Ecosystem Value Design, she is currently scoping an innovation platform for health as part of the Women in Innovation movement.
Eugene Borukhovich is a serial intra and entrepreneur currently serving as a Global Head of Digital Health (G4A) at Bayer. He is also an Entrepreneur in Residence at Personal Health Solutions (PHS) Capital, as well as an advisor to numerous digital health startups. Eugene enjoys mentoring startups and an avid blogger about innovation, digital health and startups. He can be found at HealthEugene.com.
Frank Sieren, 52, is a bestselling author, documentary film-maker and Asia specialist. His latest book “Future? China!” was published in October 2018 and again became one of the 20 bestselling books in Germany. Mr. Sieren has been living in China since 1994. The London Times calls him one of the “decisive China authorities“. Sieren, who studied political science with a focus on economics in Berlin, is the only western business journalist who has lived in China for such a long time. No other German has written more China books and no other author on China has reached the German bestseller list more often.
Dr. Eyal Zimlichman is currently Chief Medical Officer and Chief Innovation Officer at Sheba Medical Center, Israel's largest hospital. Prior to this Dr. Zimlichman has held the position of Lead Researcher at Partners Health Care Clinical Affairs Department in Boston. Dr. Zimlichman holds an appointment at Brigham and Women’s Hospital and Harvard Medical School where he is conducting research on implementing technology to improve quality and patient safety. Eyal is certified in internal medicine, is a graduate of the Harvard School of Public Health and has earned his MD at the Technion Israel Institute of Technology.
Feodora Lenz is a member of the innovation and cooperation team at the University of Göttingen. As an innovation scout, she supports the link between research and businesses in order to combine the expertise and ideas from scientists with local small and medium sized enterprises to solve R&D problems in joint projects. Within the university, she also looks for start-up ideas from research projects and supports the interdisciplinary exchange of ideas between scientists from different disciplines in order to facilitate new applied research projects. Feodora Lenz has a scientific background in astrophysics and gained entrepreneurial experience as the founder of flenz baby carriers.
Dr.-Ing. Frerk Müller-von Aschwege has a PHD in Computer Science focusing on model based telemedical exercise supervision of patients suffering from cardio vascular deceases. He has more than 10 years of research experiences in telemedical supervision of patients in mobile or ambulatory settings. He researched in more than 10 national and European projects and took leading positions especially in the field of smart device based systems. Research interests are focusing on on/in-body sensing and acting as well as standard based interoperability within the healthcare sector. Since 2018 Frerk is managing the biomedical devices and systems group at OFFIS focusing on smart telemedical technologies such as early thrombosis detection in left ventricular assist devices or cleaning ECG-Signals from Cardiopulmonary Resuscitation (CPR) artifacts for usage in Automated External Defibrillators (AED).